1	General features
1.1	Domain	T Cell Assays in Immune Monitoring
1.2	Document Type	Initial guidelines
1.3	Group	Main initiators of this effort are the Cancer Vaccine Consortium (CVC/CRI), the Cancer Immunotherapy Consortium (CIMT), and the Immune Monitoring Center at Stanford University. The final guidelines are envisioned to be an immune monitoring field-wide accomplishment.
1.4	Main Website	http://www.miataproject.org/
1.5	MI Checklist's Name	Minimal Information About T Cell Assays
1.6	MI Checklist's Acronym	MIATA
1.7	Current Version Designation	v 0.0
1.8	Release Date for Current Version	2009-10-16
1.9	General Comments	MIATA modules listed on web site for public consultation; comments posted also on web site, update of v0.0 in Q1-2010; first public workshop on March 20, 2010 at CVC meeting in Washington, DC (http://www.cancerresearch.org/programs/research/cancer-vaccine-consortium/meetings.html http://www.cancerresearch.org/programs/research/cancer-vaccine-consortium/meetings.html)

2	Contact Person
2.1	Full Name	Sylvia Janetzki, MD
2.2	Email Address	sylvia[@]zellnet.com

2	Contact Person
2.1	Full Name	Cedrik Britten, MD
2.2	Email Address	britten[@]uni-mainz.de

3	Key Concepts
3.1	Concept	Sample preparation
3.1	Concept	Assay
3.1	Concept	Data acquisition
3.1	Concept	Interpretation of results
3.1	Concept	Lab environment

4	Bibliography
4.1	PubMed Identifier	19833080
4.2	Digital Object Identifier	10.1016/j.immuni.2009.09.007
4.3	URL	http://download.cell.com/immunity/pdf/PIIS1074761309004191.pdf?intermediate=true

5	Location of Documents
5.1	Description	MIATA introduction
5.2	URL	http://download.cell.com/immunity/pdf/PIIS1074761309004191.pdf?intermediate=true